Group 1 - The core viewpoint of the news is that 乐心医疗 (Loxin Medical) has experienced a significant stock price increase, rising 5.15% to 16.14 CNY per share, with a total market capitalization of 3.528 billion CNY and a cumulative increase of 10.19% over three days [1] - 乐心医疗 specializes in home health management, focusing on the research, production, and sales of home medical health electronic products, as well as the development and operation of the 乐心智能健康云平台 (Loxin Smart Health Cloud Platform) [1] - The revenue composition of 乐心医疗 includes 66.29% from home medical products, 24.17% from home health products, 7.55% from other sources, and 1.99% from smart wearables [1] Group 2 - The top circulating shareholder data indicates that a fund under 永赢基金 (Yongying Fund) is among the top shareholders of 乐心医疗, with the 医疗器械ETF (Medical Device ETF) newly entering the top shareholders list, holding 936,200 shares, which is 0.58% of the circulating shares [2] - The 医疗器械ETF (159883) has a total scale of 4.73 billion CNY and has achieved a year-to-date return of 11.54%, ranking 820 out of 5,517 in its category [2] - The fund manager of the 医疗器械ETF is 储可凡 (Chu Kefa), who has a total fund asset scale of 6.282 billion CNY and has achieved a best fund return of 103.17% during his tenure [3]
乐心医疗股价涨5.15%,永赢基金旗下1只基金位居十大流通股东,持有93.62万股浮盈赚取73.96万元